单中心15年随访:自体玻璃化冻融卵母细胞周期的临床结局一致且可预测
本研究回顾性分析了英国单中心2008至2022年间3182个择期自体卵母细胞冷冻周期中332个冻融卵母细胞周期的临床结局,涉及299例2015至2023年间返院使用冻卵的患者。冻卵使用返还率为14%(299/2171),共记录93例临床妊娠和77例健康活产。结论认为返还率与临床结局与其他近期报告一致,挑战了关于择期冻卵的普遍批评性叙述,结果已可与常规IVF媲美。
要点
- 冻卵返还率为14%(299/2171),每移植胚胎活产率按冻存年龄分层为<35岁26%、35-39岁20%、≥40岁5%。
- 新鲜移植每移植周期活产率24%(39/163),每移植胚胎活产率17%(39/227)。
- 冻胚移植每移植周期活产率30%(24/80),每移植胚胎活产率27%(24/90);PGT-A选择胚胎后一次尝试活产率40% vs 未检测胚胎21%。
核心结论
- 返还使用冻卵的患者比例及临床结局与其他近期报告一致,挑战了关于择期冻卵的普遍批评性叙述,结果已可与常规IVF媲美。
- 并非所有返院使用卵母细胞者都能妊娠,但对于选择保存生育力者,冻卵可提供可重复且令人安心的结果。
研究设计与样本
- 回顾性观察性研究,分析英国单中心2008至2022年间3182个择期自体卵母细胞冷冻周期所衍生的332个自体冻融卵母细胞周期。
- 分析299例于2015至2023年间返院使用冻卵的患者结局。
主要发现
- 共在2280例患者中实施3328个择期卵母细胞玻璃化冷冻周期,冻卵返还使用率为14%(299/2171)。
- 冻存时平均年龄37.6岁,复温时平均年龄40岁;记录93例临床妊娠和77例健康活产。
- 新鲜移植每移植周期活产率24%(39/163),每移植胚胎活产率17%(39/227)。
- 按冻存年龄分层,每移植胚胎活产率<35岁为26%(12/47),35-39岁为20%(24/118),≥40岁为5%(3/62)。
- 冻胚移植每移植周期活产率30%(24/80),每移植胚胎活产率27%(24/90);PGT-A选择胚胎后一次尝试活产率40% vs 未检测胚胎冻胚移植21%;≥40岁患者整倍体冻胚移植每患者累积活产率达42%。
临床怎么用
- 作者认为,冻卵返还率与临床结局与其他近期报告一致,结果已可与常规IVF媲美,挑战了关于择期冻卵的普遍批评性叙述。
- 作者指出,并非所有返院使用卵母细胞者都能妊娠,但对于选择保存生育力者,冻卵可提供可重复且令人安心的结果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: What were the clinical outcomes from 332 autologous vitrified- warmed oocyte cycles derived from 3182 elective autologous oocyte freeze cycles carried out between 2008 and 2022 in a single-centre series? DESIGN: In this retrospective observational study, outcomes in 299 patients returning to use their frozen oocytes between 2015 and 2023 were analysed. RESULTS: A total of 3328 elective oocyte vitrification cycles were performed in 2280 patients. The return rate to use oocytes was 14% (299/2171). Mean ages were 37.6 years at storage and 40 at warming. Ninety-three clinical pregnancies and 77 healthy live births were recorded. The live birth rate (LBR) was 24% (39/163) per fresh transfer and 17% (39/227) per embryo transferred. Stratified by age at freezing, the LBR per embryo transferred was 26% (12/47) in participants under 35 years, 20% (24/118) in those 35-39 years and 5% (3/62) in those 40+ years. Frozen embryo transfers (FET) achieved a 30% (24/80) LBR per embryo transfer and a 27% (24/90) LBR per embryo transferred. PGT-A for embryo selection doubled the LBR compared with FET from an untested embryo after one attempt (40% versus 21%). In patients aged over 40 years, the cumulative LBR reached 42% per patient in euploid FET. CONCLUSION: The proportion of patients who returned to use their stored oocytes and the clinical outcomes were consistent with other recent reports and challenges the prevalent critical narrative regarding elective oocyte freezing for fertility preservation. The results are now comparable to routine IVF. Not everyone who returns to use their oocytes will conceive, but for those choosing to preserve their fertility, oocyte freezing can provide reproducible and reassuring results.
引用
- Garratt J, Shah T, Mclaughlin A, et al. Clinical outcomes of vitrified-warmed autologous oocyte cycles with 15-year follow-up at a single UK centre: consistent and predictable results. Reprod Biomed Online. 2024. PMID: 39025683. doi:10.1016/j.rbmo.2024.104376
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。